The percutaneous coronary intervention has undergone rapid evolution over the last 40 years and has become one of the most widely performed medical procedures. The introduction of intracoronary stents improved the safety and efficacy of percutaneous coronary intervention. But with the advent of stenting, a new potentially fatal enemy emerged: stent thrombosis. Ever since, adjunct pharmacological therapy, stent technique and technology have been adjusted to reduce the risk of stent thrombosis. The aim of the present article is to provide an overview of past, present and future aspects of percutaneous intervention in relation to stent thrombosis.

Coronary atherosclerosis, Scaffold thrombosis, Stent thrombosis
dx.doi.org/10.20452/pamw.4180, hdl.handle.net/1765/104424
Polskie Archiwum Medycyny Wewnetrznej
Erasmus MC: University Medical Center Rotterdam

Kerkmeijer, L.S. (Laura S.), Tenekecioglu, E, & Wykrzykowska, J.J. (2018). Stent thrombosis in patients with drug-eluting stents and bioresorbable vascular scaffolds. Polskie Archiwum Medycyny Wewnetrznej (Vol. 128, pp. 943–950). doi:10.20452/pamw.4180